Rankings
▼
Calendar
CMMB Q4 2021 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena
CMMB
Chemomab Therapeutics Ltd.
$12M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$11,050
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-1.77
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$64M
Total Liabilities
$3M
Stockholders' Equity
$61M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$11,050
$0
—
Operating Income
-$5M
-$2M
-158.7%
Net Income
-$5M
-$2M
-158.1%
← FY 2021
All Quarters
Q1 2022 →